Short-acting inhaled β-agonists: To be taken regularly or as needed?

Lancet

Volumn 355, Issue 9216, 2000, Pages 1658-1659

  Sears, M R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FENOTEROL; ISOPRENALINE; METHACHOLINE; SALBUTAMOL;

ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MOTOR DYSFUNCTION; NOTE; PEAK EXPIRATORY FLOW; POWDER INHALER; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE;

EID: 0034643635     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02231-5     Document Type: Note

References (20)

1. GL Shepherd MR Hetzel TJH Clark Regular versus symptomatic aerosol treatment of asthma Br J Dis Chest 75 1981 215 217
2. JD Wilson DC Sutherland AC Thomas Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet i 1981 1235 1237
3. FE Speizer R Doll P Heaf Observations on recent increase in mortality from asthma BMJ i 1968 335 339
4. MR Sears HH Rea RPG Rothwell Asthma mortality: comparison between New Zealand and England BMJ 293 1986 1342 1345
5. MR Sears DR Taylor CG Print Regular inhaled beta-agonist treatment in bronchial asthma Lancet 336 1990 1391 1396
6. DR Taylor MR Sears GP Herbison Regular inhaled β-agonist in asthma: effect on exacerbations and lung function Thorax 48 1993 134 138
7. MS Ellman CM Viscoli MR Sears DR Taylor WS Beckett RI Horwitz A new index of prognostic severity for chronic asthma Chest 112 1997 582 590
8. 2-agonist controversy: observations, explanations and relationship to asthma epidemiology Drug Safety 11 1994 259 283
9. R Beasley C Burgess N Pearce K Woodman J Crane Confounding by severity does not explain the association between fenoterol and asthma death Chin Exper Allergy 24 1994 660 668
10. JM Drazen E Israel HA Boushey Comparison of regularly scheduled with as-needed use of albuterol in mild asthma N Engl J. Med 335 1996 841 847
11. DR Taylor GI Town GP Herbison Asthma control during long term treatment with regular inhaled salbutamol and salmeterol Thorax 53 1998 744 752
12. R Bhagat VA Swystun DW Cockcroft Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response J Allergy Clin lnmmunol 97 1996 47 52
13. DW Cockcroft CP McPaarland SA Britto VA Swystun BC Rutherford Regular inhaled salbutamol and airway responsiveness to allergen Lancet 342 1993 833 837
14. DW Cockcroft PM O'Byrne VA Swystun R Bhagat Regular use of inhaled salbutamol and the allergen-induced late asthmatic response J Allergy Clin Immunol 96 1995 44 49
15. MD Inman PM O'Byrne The effect of regular inhaled albuterol on exercise-induced bronchoconstriction Am J Respir Crit Care Med 153 1996 65 69
16. GM Gauvreux M Jordana RM Watson DW Cockcroft PM O'Byrne Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects Am J Respir Crit Care Med 156 1997 1738 1745
17. MR Sears Epidemiological trends in asthma Can Respir J 3 1996 261 268
18. DR Taylor MR Sears Bronchodilators and bronchial hyperresponsiveness Thorax 49 1994 190
19. Richter B, Bender R, Berger M. Effects of on-demand and regular beta2-agonist inhalation in moderate-to-severe asthma. J Intern Med (in press).
20. RA Pauwels C-G Lofdahl DS Postma Effect of inhaled formoterol and budesonide on exacerbations of asthma N Engl J Med 337 1997 1405 1411